About 1 in 10 U.S
Another limitation of GLP-1 RAs is that discontinuation commonly leads to substantial body weight regain, and many patients who regain weight subsequently restart GLP-1 RA therapy, resulting in a recurrent cycle of body weight loss and gain [10]
So, lets discuss three strategies that lead to higher GLP-1 levels
In a recent study published in the International Journal of Obesity , researchers investigated the effects of combined glucagon-like peptide 1 (GLP-1) analog and bupropion/naltrexone treatment on weight loss
For many, its not drug efficacybut a mix of cost, access, side effects, systemic barriers, and in some cases, dosing strategies like microdosing that may work for certain individuals but arent universally supported by clinical guidelines
Will I lose more weight on tirzepatide